2008 Annual Report and Accounts and Notice of AGM
May 22 2009 - 2:00AM
UK Regulatory
TIDMMDST
RNS Number : 6857S
Medicsight Plc
22 May 2009
+------------------------------------+------------------------------------+
| Press Release | 22 May 2009 |
+------------------------------------+------------------------------------+
Medicsight PLC
("Medicsight" or "the Company")
2008 Annual Report and Accounts and notice of AGM
In accordance with Rule 20 of the AIM Rules, Medicsight PLC (AIM: MDST), an
industry leader in the development of Computer-Aided Detection (CAD) and image
analysis software, confirms that the Annual Report and Accounts for the year
ended 31 December 2008, the notice of the Annual General Meeting and the form of
proxy, were posted to shareholders today and are also available to view on the
Company's website at www.medicsight.com.
The Annual General Meeting will be held at Kensington Centre, 66 Hammersmith
Road, London W14 8UD at 12 noon on Wednesday 17th June 2009.
- ENDS -
For further information:
+----------------------------------------------+--------------------------+
| Medicsight PLC | |
+----------------------------------------------+--------------------------+
| Allan Rowley, CEO | Tel: +44 (0)20 7605 |
| | 7950 |
+----------------------------------------------+--------------------------+
| | www.medicsight.com |
+----------------------------------------------+--------------------------+
| Daniel Stewart & Co | |
+----------------------------------------------+--------------------------+
| Simon Leathers | Tel: +44 (0) 207 776 |
| | 6550 |
+----------------------------------------------+--------------------------+
| | www.danielstewart.co.uk |
+----------------------------------------------+--------------------------+
Media enquiries:
+----------------------------------------------+-------------------------+
| Abchurch | Tel: +44 (0) 20 7398 |
| | 7700 |
+----------------------------------------------+-------------------------+
| Heather Salmond/Stephanie Cuthbert/Simone | Tel: +44 (0) 20 7398 |
| Alves | 7728 |
+----------------------------------------------+-------------------------+
| stephanie.cuthbert@abchurch-group.com | www.abchurch-group.com |
+----------------------------------------------+-------------------------+
Notes to editors
Medicsight PLC is a UK-headquartered, research driven, leading developer of
computer-aided detection (CAD) and image analysis software for the medical
imaging market. The CAD software automatically highlights suspicious areas on
computerised tomography (CT) scans of the colon and lung,
helping radiologists to identify, measure and analyse potential disease and
early indicators of disease. Medicsight's CAD software has been validated using
one of the world's largest and most population diverse databases of verified
patient CT scan data. Medicsight's ColonCAD(TM) and LungCAD(TM) software
products are seamlessly integrated with the advanced 3D visualisation
workstations of several industry-leading imaging equipment partners.
About Computer-Aided Detection
With increasingly sophisticated radiological imaging hardware such as
Multi-Detector CT scanners, radiologists are facing a growing challenge in the
amount of detailed patient image data that they must review for each patient
examination. Some CT scan examinations generate as many as 2000 images per
patient. Review of this data by the radiologist is not only time-consuming but
also prone to error due to reader fatigue. CAD software can help the reviewing
radiologist by analysing the image data and automatically highlighting
suspicious regions of interest for closer inspection. Without CAD software some
potential abnormalities or areas of disease may be overlooked. This can
be critical for diagnosis and the management of patient outcomes as early
detection of disease greatly increases the probability of successful treatment
and a positive therapeutic outcome. In addition to supporting individual
radiologists CAD also has the potential to help standardise CT interpretation
across both individuals and institutions thereby supporting population based
screening programmes.
About Medicsight's CAD software
Medicsight's ColonCAD(TM) and LungCAD(TM) software use an advanced CAD algorithm
to analyse CT scans of the colon and lung and automatically highlight suspicious
areas that may be indicators of disease. CAD may highlight areas easily
overlooked by the reviewing radiologist, such as small lesions or regions that
are hidden from view behind folds in the colon or normal structures and
surrounding tissue in the lung.
Both CAD products seamlessly integrate with the advanced 3D visualisation
platforms of industry-leading imaging equipment partners. The integrated systems
provide sophisticated image viewing capabilities, including 3D reconstructed
image data, with the added advantage of demonstrating automatic CAD findings to
assist clinical end users in the detection and analysis of disease. This allows
clinical end users to perform either a 'second read', where CAD findings are
displayed to the user after completion of an initial review of the CT scan data,
or a 'concurrent read' where CAD findings are displayed during the user's
initial review of the original CT scan images.
Sinceinception, Medicsight has developed close and lasting relationships with
some of the world's foremost clinicians in product related areas. This provides
the Company with a wealth of clinical expertise and dedicated clinical research
to support ongoing product development. Medicsight also collaborates with a
number of leading academic institutions and clinical research programmes
worldwide to develop the Company's comprehensive database of population diverse
verified patient CT scan data, thus allowing Medicsight's products to be
validated to the highest possible standards.
This information is provided by RNS
The company news service from the London Stock Exchange
END
ACSSELFMFSUSELI
Medicsight (LSE:MDST)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medicsight (LSE:MDST)
Historical Stock Chart
From Jul 2023 to Jul 2024
